MedPath

A brief cognitive behavioural intervention for people with methamphetamine use problems

Not Applicable
Completed
Conditions
Mental Health - Depression
Mental Health - Addiction
methamphetamine use
depression
Registration Number
ACTRN12611000355976
Lead Sponsor
niversity of Newcastle
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
214
Inclusion Criteria

Regular methamphetamine use for the month prior to baseline. Regular use of amphetamines was defined as at least weekly use (a score of 0.14 or more for amphetamine use on the Opiate Treatment Index, OTI).

Exclusion Criteria

Exclusion criteria were suicidality or acute psychosis, acquired cognitive impairment and current enrolment in treatment for amphetamine use.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in methamphetamine use relative to baseline, as measured by the Opiate Treatment Index (OTI).[5 weeks post-baseline<br>6 months post-baseline];Reduction In depressive symptoms relative to baseline, as measured by the Beck Depression Inventory II.[5 weeks post-baseline<br>6 months post-baseline]
Secondary Outcome Measures
NameTimeMethod
Improvement in quality of life, as measured by the WHO quality of life scale.[5 weeks post-baseline<br>6 months post-baseline]
© Copyright 2025. All Rights Reserved by MedPath